Please use this identifier to cite or link to this item:
Title: Antibiotic allergy labels in hospitalised and critically ill adults: a review of current impacts of inaccurate labelling.
Austin Authors: Moran, Rebekah L;Devchand, Misha ;Smibert, Olivia;Trubiano, Jason A 
Affiliation: National Centre for Infections in Cancer, Department of Oncology Sir Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
Issue Date: Mar-2019 2018-12-06
Publication information: British journal of clinical pharmacology 2019; 85(3): 492-500
Abstract: Antibiotic Allergy Labels (AAL) are reported by approximately 20% of hospitalised patients, yet over 85% will be negative on formal allergy testing. Hospitalised patients with an AAL have inferior patient outcomes, increased colonization with multidrug resistant organisms and frequently receive inappropriate antimicrobials. Hospitalised populations have been well studied, yet to date the impact of AALs on patients with critical illness remain less well defined. We review the prevalence and impact of AALs on hospitalised patients, including those in in critical care.
DOI: 10.1111/bcp.13830
ORCID: 0000-0003-4377-4084
PubMed URL: 30521088
Type: Journal Article
Subjects: Penicillin allergy
acute care
antimicrobial allergy
antimicrobial stewardship
skin testing
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 25, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.